Ispecimen Inc (ISPC) Stock Price, Quote & News

Company Profile

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal m...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 781 301 6700

Website: ispecimen.com

Address:

8 Cabot Road, Woburn, United States

ChartChartist Oct. 5 at 1:28 AM

$PAVS $3 - $5 when compliance then news release. Its locked. The rest is shorts playing small. $APVO 1.4 nice $ENVB accumulation $ISPC $1 alert set

0 · Reply

Angdsz Oct. 3 at 11:10 PM

$ISPC which direction, up, or down 0.70?

2 · Reply

HeavyDtwitter Oct. 3 at 10:32 PM

$NAKA Said the same about $ISPC Voted A No ☝️

0 · Reply

graniterock Oct. 3 at 10:05 PM

$ISPC shorts are going to take advantage of the delay with their meeting until October 30th I believe, so maybe start rolling in on this a few days before that.. glta

0 · Reply

Bazzzigar Oct. 3 at 8:26 PM

$ISPC just need more volume

1 · Reply

Sw1ngb0t Oct. 3 at 8:17 PM

$INHD $EEIQ $THAR $VSTD $ISPC

0 · Reply

Sanjaynaik2011 Oct. 3 at 8:00 PM

$ISPC Since $BTC has risen, this POS is free falling

0 · Reply

Sanjaynaik2011 Oct. 3 at 7:58 PM

$ISPC Split coming up it OTC?? I hope it won't get delisted. Total TRASH!!!

0 · Reply

Zack9811 Oct. 3 at 6:53 PM

$ISPC liquid gold in first quarter next year. Add if you can. This is a 10.00 stock once the make the announcement that 50 million is in place. You need big ball to weather this situation and it will pay off.

2 · Reply

Bazzzigar Oct. 3 at 6:51 PM

$ISPC

0 · Reply

iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

Aug 21, 2025, 8:00 AM EDT - 6 weeks ago

iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform

Aug 7, 2025, 4:05 PM EDT - 2 months ago

iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow

Aug 4, 2025, 6:45 PM EDT - 2 months ago

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

Jul 31, 2025, 4:06 PM EDT - 2 months ago

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market

Jul 28, 2025, 4:35 PM EDT - 2 months ago

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Jul 28, 2025, 4:30 PM EDT - 2 months ago

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

Jul 25, 2025, 1:53 PM EDT - 2 months ago

iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Jul 24, 2025, 8:30 AM EDT - 2 months ago

iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

Jan 16, 2025, 4:01 PM EST - 9 months ago

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

Dec 20, 2024, 8:30 AM EST - 10 months ago

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

Dec 13, 2024, 7:30 AM EST - 10 months ago

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

Dec 12, 2024, 5:11 PM EST - 10 months ago

iSpecimen Appoints Robert Lim as CEO and Director

Nov 8, 2024, 7:30 AM EST - 11 months ago

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Nov 7, 2024, 7:30 AM EST - 11 months ago

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

Oct 31, 2024, 3:07 PM EDT - 1 year ago

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Oct 30, 2024, 8:30 AM EDT - 1 year ago

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Sep 26, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members

Sep 11, 2024, 4:30 PM EDT - 1 year ago

iSpecimen Announces 1-for-20 Reverse Stock Split

Aug 10, 2024, 7:14 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Reports Second Quarter 2024 Results

May 12, 2024, 8:24 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript

May 7, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Reports First Quarter 2024 Results

Apr 25, 2024, 8:00 AM EDT - 1 year ago

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 14, 2024, 10:40 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 8:00 AM EDT - 1 year ago

iSpecimen Reports Full Year 2023 Results

Mar 12, 2024, 7:07 PM EDT - 1 year ago

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

Mar 5, 2024, 4:30 PM EST - 1 year ago

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

Jan 23, 2024, 7:30 AM EST - 1 year ago

iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

Jan 18, 2024, 8:11 AM EST - 1 year ago

iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024

Dec 7, 2023, 7:30 AM EST - 1 year ago

iSpecimen Strengthens Global Oncology Biospecimen Offering

Nov 3, 2023, 4:39 PM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Reports Third Quarter 2023 Financial and Operating Results

Oct 26, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research

Oct 23, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially

Sep 28, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers

Sep 13, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Expands Provider Network to Enhance Support for Women's Health Research

Sep 6, 2023, 4:05 PM EDT - 2 years ago

iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability

Sep 6, 2023, 7:36 AM EDT - 2 years ago

Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)

BIVI OMIC

Aug 30, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Launches New Virtual Cancer Sequencing Procurement Program

Aug 16, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers

Aug 9, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers

Aug 5, 2023, 10:22 AM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 7:00 AM EDT - 2 years ago

iSpecimen Reports Second Quarter 2023 Financial and Operating Results

Jul 25, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Report Second Quarter 2023 Results on August 2, 2023

Jul 6, 2023, 7:30 AM EDT - 2 years ago

Thirteen New Biospecimen Suppliers Added to iSpecimen's Proprietary Provider Network

May 23, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023

May 6, 2023, 6:25 PM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript

May 4, 2023, 7:00 AM EDT - 2 years ago

iSpecimen Reports First Quarter 2023 Results

Apr 24, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023

ChartChartist Oct. 5 at 1:28 AM

$PAVS $3 - $5 when compliance then news release. Its locked. The rest is shorts playing small. $APVO 1.4 nice $ENVB accumulation $ISPC $1 alert set

0 · Reply

Angdsz Oct. 3 at 11:10 PM

$ISPC which direction, up, or down 0.70?

2 · Reply

HeavyDtwitter Oct. 3 at 10:32 PM

$NAKA Said the same about $ISPC Voted A No ☝️

0 · Reply

graniterock Oct. 3 at 10:05 PM

$ISPC shorts are going to take advantage of the delay with their meeting until October 30th I believe, so maybe start rolling in on this a few days before that.. glta

0 · Reply

Bazzzigar Oct. 3 at 8:26 PM

$ISPC just need more volume

1 · Reply

Sw1ngb0t Oct. 3 at 8:17 PM

$INHD $EEIQ $THAR $VSTD $ISPC

0 · Reply

Sanjaynaik2011 Oct. 3 at 8:00 PM

$ISPC Since $BTC has risen, this POS is free falling

0 · Reply

Sanjaynaik2011 Oct. 3 at 7:58 PM

$ISPC Split coming up it OTC?? I hope it won't get delisted. Total TRASH!!!

0 · Reply

Zack9811 Oct. 3 at 6:53 PM

2 · Reply

Bazzzigar Oct. 3 at 6:51 PM

$ISPC

0 · Reply

Netplus1 Oct. 3 at 4:46 PM

$ISPC

0 · Reply

Bazzzigar Oct. 3 at 3:39 PM

$ISPC few more

0 · Reply

ArlendMcfarland Oct. 3 at 3:35 PM

$ISPC take it down to .60!

1 · Reply

amir10 Oct. 3 at 2:07 PM

$ISPC i am realy impress that she not droped to 0.7 . The SOL treasury is a wishfull thinking but the market already know that it will take time

0 · Reply

Yd___TE Oct. 3 at 2:03 PM

$ISPC + $SOL.X

0 · Reply

GrimReaper1987 Oct. 3 at 1:23 PM

$ISPC Why was the shareholder meeting postponed again? Does anyone know the reason?

1 · Reply

warrenpark Oct. 3 at 11:54 AM

$ISPC acquiring 50mil+ solana in Q4 confirmed. The rest will be purchased in the next 12-24 months

2 · Reply

DDUDDU Oct. 3 at 11:23 AM

$ISPC

0 · Reply

Moneybags789 Oct. 3 at 11:04 AM

$ISPC t💣💣ick tock tick tock💣

0 · Reply

GrimReaper1987 Oct. 3 at 9:55 AM

$ISPC FUD only drives a stock higher when there’s real trading volume behind it. ISPC has almost no volume right now, which means there’s no real buying pressure. The truth is, the big players are gone and shareholders are simply left holding the bag

0 · Reply

ArlendMcfarland Oct. 3 at 5:33 AM

$ISPC upcoming shareholder meeting is old news. Good sign seeing the fud patrol on duty though

0 · Reply

peachsoda Oct. 3 at 2:19 AM

$ISPC reverse split. I’m out.

0 · Reply

Market Cap	6.32M
Revenue (ttm)	9.29M
Net Income (ttm)	-12.50M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-134.55%
Debt to Equity Ratio	0.00

Volume	1,030,100
Avg Vol	8,726,594
Day's Range	N/A - N/A
Shares Out	5.54M
Stochastic %K	5%
Beta	1.81
Analysts	Strong Buy
Price Target	$4.25